ANKS6 Inhibitors
ANKS6 inhibitors belong to a distinct chemical class renowned for their pivotal role in modulating cellular processes. The ANKS6 protein, also known as Ankyrin repeat and sterile alpha motif domain-containing protein 6, serves as a critical component in various intracellular signaling pathways. Structurally characterized by ankyrin repeats and sterile alpha motifs, ANKS6 is implicated in cellular functions such as signal transduction, protein-protein interactions, and the regulation of cellular architecture. As an integral part of cellular scaffolding, ANKS6 contributes to the assembly of multiprotein complexes and orchestrates the precise spatial organization of molecular interactions within the cell.
The inhibitors designed to target ANKS6 act by selectively binding to the active site or specific domains of the protein, thereby disrupting its normal function. Through this targeted interference, ANKS6 inhibitors offer a means to investigate the intricate molecular mechanisms underlying cellular processes governed by ANKS6. Researchers leverage these inhibitors as valuable tools in dissecting cellular signaling cascades and elucidating the functional significance of ANKS6 in health and disease. The development and refinement of ANKS6 inhibitors represent a dynamic area of research within the realm of chemical biology, holding promise for uncovering novel insights into cellular regulation and potentially informing future strategies through an enhanced understanding of ANKS6's role in cellular physiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR pathway, which is involved in cell growth and proliferation related to cyst formation. | ||||||
Captopril | 62571-86-2 | sc-200566 sc-200566A | 1 g 5 g | $49.00 $91.00 | 21 | |
An ACE inhibitor that can reduce hypertension, indirectly affecting renal function and cyst progression. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Activates AMPK, which can inhibit mTOR signaling, related to cell growth and proliferation. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
An aldosterone antagonist that modulates renal function and fluid balance. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Shows anti-inflammatory and antiproliferative effects, which can influence cyst growth. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Modulates multiple signaling pathways, potentially affecting proliferation and inflammation. | ||||||
BEZ235 | 915019-65-7 | sc-364429 | 50 mg | $211.00 | 8 | |
Dual PI3K/mTOR inhibitor, potentially affecting proliferation associated with ANKS6. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Tyrosine kinase inhibitor, may affect growth factor signaling related to cyst formation. | ||||||
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $131.00 $651.00 | 7 | |
mTOR inhibitor, similar in function to Rapamycin and Sirolimus. | ||||||
Tolvaptan | 150683-30-0 | sc-364638 sc-364638A | 10 mg 50 mg | $125.00 $624.00 | ||
Vasopressin receptor antagonist, can decrease cyst cell proliferation and fluid secretion. | ||||||